HealthPresso to raise $1 M in Pre-Series A funding round
IMT News Desk
The infusion of capital will accelerate the growth trajectory, enabling the scaling of operations & enhancement of service offerings
Health-tech startup HealthPresso is all set to raise a $1 million pre-series A funding round, instrumental in the platform's initial growth phase.
The investor community has shown substantial interest in HealthPresso, recognising the potential of its custom AI engine (HumetaTM) and extensive distribution network. This infusion of capital will accelerate the growth trajectory, enabling the scaling of operations and enhancement of service offerings.
Daleep Manhas, Co-Founder and CEO and Dr Swadeep Srivastava, Founder and Chief Belief Officer jointly said, “The investor community has shown substantial interest in HealthPresso, recognising the potential of its custom AI engine (Humeta) and extensive distribution network. This infusion of capital will accelerate the growth trajectory, enabling the scaling of operations and enhancement of service offerings.”
HealthPresso isn't just expanding its reach; it's forging a new path in Indian healthcare, one that empowers pharmaceutical giants. This innovative platform is becoming the cornerstone of therapy-shaping initiatives and physician engagement programs, a trusted partner to industry titans. But HealthPresso's influence extends far beyond individual partnerships. By joining forces with healthcare powerhouses like eLets, BW, and leading Health AI platforms, HealthPresso is solidifying its position in the healthcare content landscape.
The platform aims to support healthcare providers in navigating the complex landscape of PR, regulatory compliance, and physician engagement. HealthPresso looks forward to continuing its journey of growth and innovation in the healthcare sector.
